Results 111 to 120 of about 114,595,259 (259)
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon +11 more
wiley +1 more source
ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Eda G. Kabak +4 more
wiley +1 more source
Solving Problems with Bounds on Linear Forms in Logarithms
This expository paper explores the theory of linear forms in logarithms and its applications to Diophantine equations. We begin with foundational results on transcendental numbers, including Liouville's theorem and the Gelfond-Schneider theorem, before developing Baker's theory of linear forms in logarithms.
openaire +1 more source
Predictive Ability of Plasma p‐tau217 for β‐Amyloid Status: A Prospective Multicenter Study
ABSTRACT Objective Plasma tau phosphorylated at threonine 217 (p‐tau217) measured with fully automated platforms has shown high accuracy for Alzheimer's disease (AD) diagnosis, but real‐world multicenter data remain limited. We aimed to validate the diagnostic performance of p‐tau217 for identifying AD pathology in a real‐world multicenter cohort ...
Miquel Massons +33 more
wiley +1 more source
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Computing discrete logarithms with special linear systems
The idea to compute discrete logarithms in degree 0 class groups of non-singular proper non-hyperelliptic curves of a fixed genus over finite fields with the help of special linear systems is studied.
Claus Diem, Sebastian Kochinke
core
An algorithm for the optimisation of n-forms using symmetric multilinear forms [PDF]
This paper describes an algorithm for locating stationary points of n-forms. Use is made of the associated n-linear form, the stationary points of which are seen to coincide with those of the n-form.
Bousfield, RA
core
ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng +4 more
wiley +1 more source
An Explicit Bound for the Logarithmic Integral Derived via Linear Forms in Logarithms
This paper establishes an explicit conditional upper bound for the Eulerian logarithmic integral by bridging transcendental and analytic number theory. Specifically, we apply the Baker-Matveev method for linear forms in logarithms to a primorial-based Diophantine system.
openaire +3 more sources
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket +14 more
wiley +1 more source

